enkephalin--leucine-2-alanine and Labyrinth-Diseases

enkephalin--leucine-2-alanine has been researched along with Labyrinth-Diseases* in 1 studies

Trials

1 trial(s) available for enkephalin--leucine-2-alanine and Labyrinth-Diseases

ArticleYear
[Functioning of the pituitary-adrenal system during the vestibulo-vegetative syndrome and administration of dalargin and nalorphine].
    Biulleten' eksperimental'noi biologii i meditsiny, 1987, Volume: 104, Issue:9

    Changes in ACTH, cortisol, beta-endorphin have been investigated during vestibulo-vegetative syndrome (VVS) and injections of dalargin (leu-enkephalin analog) and nalorphine (agonist-antagonist of opioid receptors) in 9 volunteers with low level vestibulo-vegetative stability. Cumulative coriolis acceleration test during rotations on a special chair was used for VVS modelling. Dalargin (1-4 mg), nalorphine (5 mg) and placebo (NaCl solution) were injected intravenously 5-15 min before rotation. A significant increase in ACTH, cortisol and beta-endorphin plasma levels has been observed. Mean positive linear correlation (r greater than +0.6) between ACTH and beta-endorphin and ACTH and cortisol was noted immediately after the test only when dalargin was injected. It is suggested that in VVS there develops a hormonal conflict, i. e. an adequate hormonal release is disturbed.

    Topics: Autonomic Nervous System Diseases; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Humans; Labyrinth Diseases; Male; Nalorphine; Pituitary-Adrenal System; Syndrome; Vestibule, Labyrinth

1987